explore -WSS

explore

author：leisure time 2025-08-26 07:42:42 - browse：28

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Study gives hint on South Asians’ higher risk of cardiovascular disease

WSS

Artificial intelligence use in health care faces greater scrutiny in 2024

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

The wait for US passports is creating travel purgatory and snarling summer plans

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

AstraZeneca lung cancer study comes in below expectations

focus

explore

focus

The cancer drug shortage isn’t new — and neither are the solutions

Bernie Sanders gets little from pharma CEOs on drug prices

Hollywood unions extend contract negotiations for actors

Skip the lead apron during X

Medicare proposal to cover medical devices draws a mixed reaction

Congress must protect the remaining independent doctors

Apple is now the first public company to be valued at $3 trillion

Prescription digital therapeutics are key to pharma’s future

How one medical school became remarkably diverse

Websites selling Wegovy, Zepbound ingredients targeted by FDA

focus

What affirmative action's end means to a medical student

Ebola vaccine can save some who are already sick, per new study

Latigo launches with $135 million for Vertex

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Security flaws in third

Congress considering partial increase for doctor pay in Medicare

leisure time

focus

Wikipedia

entertainment